Geode Capital Management’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Other funds holding MRVI
1WCM
Geode Capital Management's MRVI Position: Q3 2026 in Review
Geode Capital Management reduced its Maravai LifeSciences (MRVI) stake by 0.38% in Q3 2026, selling an estimated $81.8K and leaving 3,118,436 shares worth $23.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2012.
Geode Capital Management first reported a position in MRVI in Q4 2020 and has held it in 24 quarters since. The position peaked at $65.5M in Q3 2021. 202 funds tracked by Wall St. Rank hold MRVI as of Q3 2026.
- Geode Capital Management held 3,118,436 shares of Maravai LifeSciences worth $23.9M as of Q3 2026.
- Geode Capital Management sold 11,822 Maravai LifeSciences shares in Q3 2026, an estimated $81.8K.
- Maravai LifeSciences made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #2012 holding.
- Geode Capital Management first reported a position in Maravai LifeSciences in Q4 2020 and has held it in 24 quarters since.
- Geode Capital Management's Maravai LifeSciences position peaked at $65.5M in Q3 2021.
- 202 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.